It has been identified how the combination of inhibitors of PP2A and WEE1 proteins induces the death of colon cancer cells, offering a new perspective in the treatment of this disease.
Read moreA clinical trial has demonstrated the potential of the amino acid L-serine, administered as an oral supplement, to improve the function of glutamate receptors in patients with GRINpathies.
Read morePalobiofarma S.L. is pleased to announce the “last patient last visit” of the Phase II trial investigating the safety and preliminary efficacy of PBF-680 in moderate to severe COPD patients.
Read moreLaminar Pharma opens a new financing round of up to seven million euros. The objective is to finish financing the development of its drug LAM561 against the most aggressive and common brain cancer, gl...
Read moreUn estudio propone un novedoso enfoque para frenar la degeneración neuromuscular en pacientes con Esclerosis Lateral Amiotrófica
Read moreEl Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico Universitario de València, ha impulsado un ensayo clínico para evaluar la seguridad y la tolerabilidad del anticuerpo blinatum...
Read moreInvestigadores del Cima Universidad de Navarra constatan que la combinación de dos fármacos, ya conocidos, abre el camino a posibles ensayos clínicos para combatir los gliomas difusos de línea med...
Read moreThis article explores the current state of pharmaceutical innovation, predicts future trends, and discusses the role of artificial intelligence in shaping the industry. Furthermore, it highlights the ...
Read more